Search

everythinglearnresearchcommunity

for

Search:↓

The diphosphonate was the most effective at preventing calcification in rats.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Both contraceptive pill doses effectively reduced androgen levels in women with PCOS.

Polymers increased skin permeation and stability of steroid hormones in liposomal formulations.

Steroid hormones change the size, charge, and stability of DPPC liposomes.

MPA improved hormonal imbalances and acne in women with PCOS without affecting metabolism.

Choosing the right estroprogestin is crucial for effectively managing PCOS symptoms.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

The combination therapy effectively treats infertility in PCOS without major side effects.

The birth control combination of ethinylestradiol and drospirenone helps treat symptoms of polycystic ovary syndrome.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

PPCM microspheres allow controlled finasteride release over 24 hours.

Dienogest combined with ethinylestradiol is a highly effective birth control that improves menstrual symptoms and has manageable side effects.

The treatment temporarily improved symptoms of hyperandrogenism in adolescents.

Trienones are more effective at inhibiting the enzyme linked to hair loss than dienones.

Low-dose oral contraceptives reduced hair growth and testosterone levels in women with polycystic ovary syndrome.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

The treatment effectively reduces menopausal symptoms and is well tolerated.

Finasteride, a drug used for anti-hyperplasia, can be effectively delivered in the form of matrix tablets.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

The new drug delivery systems made with surfactants and block polymers are stable and not toxic.

The new nanocarriers improve how well water-insoluble drugs dissolve and allow for controlled drug release.

PPCM microspheres can effectively release finasteride over 42 days.

A new antiandrogen compound was made and its detailed three-dimensional shape was described.

17β-estradiol lowers polyamine oxidase levels in breast cancer cells through estrogen receptor 2.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.

A new method was developed to make a compound used in finasteride and epristeride with a 69% yield.

Women with PCOS have higher 5alpha-reductase activity, affecting steroid levels.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.